Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

45.38
-1.8400-3.90%
Post-market: 45.550.1700+0.37%17:40 EDT
Volume:37.32M
Turnover:1.70B
Market Cap:201.44B
PE:13.34
High:46.49
Open:45.97
Low:45.05
Close:47.22
Loading ...

Novo Nordisk downgraded to Neutral from Buy at UBS

TIPRANKS
·
05 Aug

Novo Nordisk Offers Greater Value Proposition With Promising Upside, Surpassing Eli Lilly

Trading Random
·
05 Aug

Barclays Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
05 Aug

Novo Nordisk Faces Legal Storm Over Misleading Projections

TIPRANKS
·
05 Aug

Goldman Sachs Keeps Their Buy Rating on Novo Nordisk (0QIU)

TIPRANKS
·
04 Aug

Novo Nordisk A/S expected to post earnings of DKK6.05 a share - Earnings Preview

Reuters
·
04 Aug

Why Novo Nordisk Stock Bumped Higher on Friday

Motley Fool
·
02 Aug

The Score: Meta Platforms, Whirlpool, Novo Nordisk and More Stocks That Defined the Week -- WSJ

Dow Jones
·
02 Aug

McDonald's, Palantir and Novo Nordisk Earnings: What to Watch Next Week -- WSJ

Dow Jones
·
02 Aug

Novo Nordisk Receives FDA Approval for Alhemo to Prevent Bleeding in Hemophilia A, B Without Inhibitors

MT Newswires Live
·
01 Aug

Novo Jumps 2% as US Reported To Mull Obesity-Drug Coverage

Tiger Newspress
·
01 Aug

Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck -- WSJ

Dow Jones
·
01 Aug

Novo Shares Sinks Another 3%. Novo Nordisk Loses Spot Among Europe's 10 Most Valuable Firms

Tiger Newspress
·
01 Aug

European Pharma Shares Fall After Trump Asks For Drug Price Cuts -- Market Talk

Dow Jones
·
01 Aug

Ozempic first mover sheds $170B in 4 days: Here's 2 ideas we're backing instead

LiveWire
·
01 Aug

Why Novo Nordisk Stock Crumbled Again Today

Motley Fool
·
01 Aug

Novo Nordisk Shares Drop After HSBC Downgrade

MT Newswires Live
·
01 Aug

Stock Track | Novo Nordisk Plummets 5% After HSBC Downgrades to Hold, Slashes Price Target

Stock Track
·
01 Aug

Novo Nordisk downgraded to Hold from Buy at HSBC

TIPRANKS
·
31 Jul

Novo Nordisk Q2 Preview: Can It Reclaim Its 'Weight Loss Wonder Drug' Ground Amid Three Key Challenges?

Earnings Agent
·
31 Jul